CD10367

· Galderma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD10367, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CD10367 in Psoriasis Vulgaris [Phase 2]